Mark A. Mintun
Eli Lilly (United States) · 523 works · 77,510 citations · h-index 130
Top works
- Positron emission tomographic studies of the cortical anatomy of single-word processing
- Enhanced Detection of Focal Brain Responses Using Intersubject Averaging and Change-Distribution Analysis of Subtracted PET Images
- Improved Assessment of Significant Activation in Functional Magnetic Resonance Imaging (fMRI): Use of a Cluster‐Size Threshold
- Nonoxidative Glucose Consumption During Focal Physiologic Neural Activity
- Noninvasive functional brain mapping by change-distribution analysis of averaged PET images of H215O tissue activity.
- Mapping human visual cortex with positron emission tomography
- Spatial working memory in humans as revealed by PET
- Positron Emission Tomographic Studies of the Processing of Singe Words
- A Highly Accurate Method of Localizing Regions of Neuronal Activation in the Human Brain with Positron Emission Tomography
- Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans
- A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography
- Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory
- [ 11 C]PIB in a nondemented population
- A Noninvasive Approach to Quantitative Functional Brain Mapping with H 2 15 O and Positron Emission Tomography
- Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression
- BRAIN WORK AND BRAIN IMAGING
- Donanemab in Early Symptomatic Alzheimer Disease
- Cerebrospinal Fluid tau/β-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults
- Donanemab in Early Alzheimer’s Disease
- Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands